These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 11364791

  • 1. Long-term strategies: should some patients wait to start protease inhibitors? Interview with Keith Henry, M.D. Interview by John S. James.
    Henry K.
    AIDS Treat News; 1997 Oct 17; (No 281):1, 3-6. PubMed ID: 11364791
    [Abstract] [Full Text] [Related]

  • 2. HIV research overview: interview with David Ho, M.D. Interview by John S. James.
    Ho D.
    AIDS Treat News; 1997 Nov 07; (No 282):1-6. PubMed ID: 11364903
    [Abstract] [Full Text] [Related]

  • 3. AIDS practice issues today: interview with Paul Bellman, M.D. Interview by John S. James.
    Bellman P.
    AIDS Treat News; 2000 Apr 07; (No 340):1-6. PubMed ID: 11367198
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. How far can you knock down HIV? An interview with David D. Ho, MD. Interview by Mark Mascolini.
    Ho DD.
    J Int Assoc Physicians AIDS Care; 1997 Jun 07; 3(6):40-4. PubMed ID: 11364429
    [Abstract] [Full Text] [Related]

  • 7. Virologic failure and salvage therapy.
    HIV Hotline; 1998 Mar 07; 8(1):2-3. PubMed ID: 11365357
    [Abstract] [Full Text] [Related]

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Mar 07; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 9. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS.
    AIDS; 2008 Nov 12; 22(17):2371-80. PubMed ID: 18981777
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical implications of virological "failure": interview with Steven Deeks, M.D., San Francisco General Hospital. Interview by John S. James.
    Deeks S.
    AIDS Treat News; 1998 Feb 20; (No 289):1-6. PubMed ID: 11365047
    [Abstract] [Full Text] [Related]

  • 12. The great salvage therapy drug juggle.
    Cadman J.
    GMHC Treat Issues; 1998 Apr 20; 12(4):1-6. PubMed ID: 11365398
    [Abstract] [Full Text] [Related]

  • 13. Half-full or half-empty: no simple answer on protease inhibitor failure.
    Torres G.
    GMHC Treat Issues; 1997 Oct 20; 11(10):1-2. PubMed ID: 11364818
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adherence and double therapies: an interview with Charles Farthing, M.D. Interview by Marcelo Marer.
    Farthing C.
    Body Posit; 1998 Oct 20; 11(4-5):28-33. PubMed ID: 11365254
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A kinder, gentler approach to treatment. Interview by Paul Simmons.
    Mauss S.
    Res Initiat Treat Action; 1998 Aug 20; 4(5):3-5. PubMed ID: 11365708
    [Abstract] [Full Text] [Related]

  • 20. When and where to start: guidelines for the initiation of antiretroviral therapy.
    Volberding P.
    AIDS Read; 2000 Mar 20; 10(3):150-5; discussion 171-4. PubMed ID: 10758014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.